Hemlibra (emicizumab), the only treatment currently available for haemophilia A via the NHS that doesn't require an ...

From trade associations to medtech innovators and biotech start-ups, here’s a comprehensive look at the latest boardroom ...

"For decades, bureaucrats and entrenched interests buried health data and blocked patients from taking control of their ...

In a new study, the large-language model (LLM) ChatGPT was able to reduce the time needed to review whether a patient is suitable for a clinical trial and delivered big reductions – from an average of ...

President Donald Trump has given leading pharma manufacturers a 60-day deadline to come up with a most favoured nation (MFN) ...

The target is to reduce its workforce to less than 5,000 from a level of 5,800 at the end of 2024, said chief executive ...

The foundational model could also assist Google and partner Samsung in an ongoing rivalry with Apple, currently the leader in ...

The results of the SURPASS-CVOT trial showed that dual GLP-1/GIP agonist Mounjaro (tirzepatide) was as effective as Lilly's ...

AI, integrated customer journeys, and breaking down internal silos aren’t just trends – they’re business imperatives. In this ...

The C-Suite Innovators' Playbook is brought to you in partnership with EVERSANA.

At ASCO 2025, Actuate gave an oral presentation on positive Phase 2 combination data for elraglusib, highlighting its ...

In the current climate of capital constraints, tariffs, and policy uncertainty, as well as changing regulatory dynamics, ...